A Novel Method to Estimate Levels of Receptors Using an Allosteric Modulator: Focus on Muscarinic M1 Receptor
- PMID: 37464158
- DOI: 10.1007/978-1-0716-3307-6_1
A Novel Method to Estimate Levels of Receptors Using an Allosteric Modulator: Focus on Muscarinic M1 Receptor
Abstract
This chapter outlines some of the general principles that need to be considered when developing a radioligand binding assay to measure the affinity and density of radioligand binding to a receptor in tissue or on cells. In addition it describes an innovative step forward in using radioligand binding assays to measure levels of muscarinic M1 receptors in human postmortem CNS, using both membrane binding and in situ radioligand binding. These examples show how, using receptor-specific allosteric modulators, it is possible to gain an estimate of the density of a single receptor using a radioligand that is not totally specific to the target site of interest. Given there is a growing understanding that there are problems with antibodies not showing specificity to their supposed target protein, well-characterized radioligand binding techniques still provide an important tool when studying receptor density in tissues and cells.
Keywords: Autoradiography; Muscarinic M1 receptor; Muscarinic receptors; Phosphor imaging; Radioligand binding; Tissue homogenization.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.Int J Neuropsychopharmacol. 2019 Oct 1;22(10):640-650. doi: 10.1093/ijnp/pyz045. Int J Neuropsychopharmacol. 2019. PMID: 31428788 Free PMC article.
-
A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.Assay Drug Dev Technol. 2010 Jun;8(3):356-66. doi: 10.1089/adt.2009.0257. Assay Drug Dev Technol. 2010. PMID: 20233092
-
Towards a high-affinity allosteric enhancer at muscarinic M1 receptors.J Mol Neurosci. 2002 Aug-Oct;19(1-2):123-7. doi: 10.1007/s12031-002-0022-6. J Mol Neurosci. 2002. PMID: 12212769
-
Allosteric interactions at muscarinic cholinoceptors.Clin Exp Pharmacol Physiol. 1998 Mar-Apr;25(3-4):185-94. doi: 10.1111/j.1440-1681.1998.t01-4-.x. Clin Exp Pharmacol Physiol. 1998. PMID: 9590567 Review.
-
Allosteric modulators targeting CNS muscarinic receptors.Neuropharmacology. 2018 Jul 1;136(Pt C):427-437. doi: 10.1016/j.neuropharm.2017.09.024. Epub 2017 Sep 18. Neuropharmacology. 2018. PMID: 28935216 Review.
References
-
- McKinney M (2006) Practical aspects of radioligand binding. Curr Protoc Pharmacol Suppl 33:1.3.1–1.3.42
-
- McCrea KE, Herzog H (2000) Radioligand binding studies. In: Balasubramania A (ed) Neuropeptide Y protocols. Humana Press, London
-
- Mancama D, Arranz MJ, Landau S, Kerwin R (2003) Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 119:2–6 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources